WS/T 411-2024 in English
VALIDStandards for antifungal susceptibility testing of filamentous fungi Broth dilution method
- Issued on:2024-04-02
- Implemented on:2024-09-01
- File Format:PDF
- Delivery:Via email within 5 business days
$359.00
本标准规定了微量和宏量肉汤稀释法检测抗丝状真菌药物最低抑菌浓度(Minimal Inhibitory Concentration, MIC)的参考方法。
本标准适用于引起深部真菌感染的产孢丝状真菌的药物敏感性试验,包括曲霉属某些种(Aspergillus spp.)及种复合群、镰刀菌属某些种(Fusarium spp.)及种复合群、根霉属某些种(Rhizopus spp.)和毛霉目Mucorales(接合菌纲Zygomycetes)、多育节荚孢霉(Lomentospora
prolificans,原多育赛多孢霉(Scedosporium prolificans)和申克孢子丝菌复合群的菌丝相,以及
引起皮肤真菌感染的毛癣菌属某些种(Trichophyton spp.)、小孢子菌属某些种(Microsporum spp.)
和表皮癣菌属某些种(Epidermophyton spp.)。
本标准不适用于检测双相真菌如皮炎芽生菌(Blastomyces dermatitidis)、荚膜组织胞浆菌(Histoplasma capsulatum)、粗球孢子菌属(Coccidioides spp.)、马尔尼菲篮状菌(Talaromyces marneffei)及酵母样真菌的药敏试验,也不适用于检测棘白菌素类对皮肤真菌以及环吡酮、灰黄霉素或特比萘芬类对非皮肤真菌的药敏试验。
Introduction
Core changes in the standard revision
| 2013 version | Main updates of the 2024 version |
|---|---|
| Single CLSI standard | New EUCAST standard, Appendix E fully includes the quality control scope and breakpoints |
| 5 categories of antifungal drugs | Expanded to 11 categories, and new dermatophyte drugs such as anidulafungin and ciclopirox |
| Basic ECV value | Improved ECV/ECOFF system, distinguishing wild-type from non-wild-type strains |
Key technical specifications
1.
Use RPMI-1640 broth culture medium, key steps:
- Water-insoluble drugs need to be dissolved in DMSO (final concentration ≤1%)
- Amphotericin B detection range 0.0313-16 μg/mL
- Echinocandins need to be labeled with MEC value
2. Key points for bacterial suspension preparation
| Bacterial strain type | Culture conditions | OD value range |
|---|---|---|
| Aspergillus | 35℃×7d(PDA) | 0.09-0.13(530nm) |
| Mucorales | 35℃×48h | 0.15-0.17 |
| Dermatophytes | Oatmeal medium×4-5d | Hemacytometer |
Comparison of two systems for result interpretation
Key differences between CLSI and EUCAST
Voriconazole interpretation for Aspergillus fumigatus:
CLSI breakpoint: sensitive ≤0.5 μg/mL; EUCAST breakpoint: sensitive ≤0.25 μg/mL
Quality control strain culture time:
CLSI requires 48-72h, EUCAST uniformly requires 48h
Implementation suggestions
- The laboratory should establish a -70℃ strain preservation system (subculture verification every 3 months)
- Dermatophyte testing requires a dedicated oatmeal culture medium
- ECV value reports must indicate "non-clinical efficacy prediction indicator"

Loading PDF document...
Error loading PDF. Please make sure the file is valid and try again.
We also recommend
-

WS/T 491-2024 in English
Guidelines for non-specific syphilis antibody testing
2024-05-09 -

WS/T 442-2024 in English
Clinical Laboratory Biosafety Guidelines
2024-04-02 -

WS/T 661-2020 in English
Guidelines of venous blood specimen collection
2020-03-26 -

WS/T 414-2024 in English
Analysis of the reasons for failure of external quality assessment
2024-05-09